
Care Health Insurance, one of India’s leading standalone health insurers, reported steady growth in H1 FY26, supported by rising demand for health coverage. However, the company’s financial performance highlights a growing concern across the insurance sector — claims inflation is outpacing premium growth, putting pressure on core profitability.
During the first half of FY26, Care Health generated ₹3,377 crore in gross written premiums, compared to ₹3,137 crore in the same period last year. Growth was driven by strong retail demand, expanding agent networks, and continued penetration of health insurance across India.
Top-line momentum remains intact, reinforcing Care Health’s position as a key beneficiary of India’s under-insured population.
Claims expenses rose significantly to ₹2,480 crore, up from ₹2,043 crore in H1 FY25. This sharp increase reflects:
Medical cost inflation
Higher hospitalisation expenses
Increased utilisation post-pandemic
As a result, claims growth materially exceeded premium growth, eroding underwriting margins.
Despite healthy premium growth, Care Health reported an underwriting loss, with operating performance slipping into the red. Rising commissions and operating expenses further added to the pressure, pushing the combined ratio above 100 — a clear sign that underwriting operations alone are not yet profitable.
Care Health still managed to report a modest net profit of ₹17 crore, largely due to strong investment income. Elevated interest rates and a stable investment portfolio helped offset underwriting losses, underscoring the importance of non-core income in the insurer’s overall profitability.
Care Health’s performance mirrors broader structural challenges within India’s health insurance industry:
Persistent medical inflation
Lag between cost increases and premium repricing
Higher reliance on reinsurance
Pressure on claims and expense ratios
These factors continue to weigh on underwriting margins across the sector.
Care Health Insurance remains a high-growth insurer with expanding distribution and strong demand fundamentals. However, the sustainability of earnings will depend on the company’s ability to:
Improve claims management
Enforce pricing discipline
Control operating and acquisition costs
Until underwriting profitability stabilises, investment income will remain a key earnings support.
H1 FY26 results show that Care Health is growing — but growth alone is not enough. With claims rising faster than premiums, the focus must shift toward margin protection and underwriting discipline.
For investors, Care Health represents a long-term insurance penetration story, but one where near-term performance will be closely tied to how effectively the company navigates claims inflation and cost control.
Comments